1.Zidovudine may competitively inhibit the intracellular phosphorylation of stavudine. Therefore, use of zidovudine in combination with Stavudine is not recommended.

齊多夫定會競爭性抑制司他夫定的磷酸酰化，因此禁止與齊多夫定聯(lián)合用藥。

2.Zidovudine may competitively inhibit the intracellular phosphorylation of stavudine. Therefore, use of zidovudine in combination with Stavudine is not recommended.

齊多夫定會競爭性抑制司他夫定的磷酸?；虼私古c齊多夫定聯(lián)合用藥。

3.Methods to develop zidovudine tablets with the technology of wet method pelletization and to determine the content of zidovudine tablets by HPLC.

方法以濕法制粒工藝制備齊多夫定片，采用高效液相色譜法對其進(jìn)行含量測定。

4.The present invention relates to one kind of polyethylene glycol modified zidovudine conjugate and its preparation process and application.

本發(fā)明涉及一種聚乙二醇修飾齊多夫定綴合物及其制備方法與應(yīng)用。

5.The invention discloses application of zidovudine lipid derivative in medicaments for treating virus associated diseases.

本發(fā)明公開了齊多夫定脂質(zhì)衍生物在治療與病毒有關(guān)疾病藥品中的應(yīng)用。

6.A few drugs have harmful effects when used together and should not be combined (an example is stavudine and zidovudine).

某藥物一起使用時的會產(chǎn)生有害影響，不應(yīng)組合使用(例如司他夫定和齊多夫定)。

7.Zidovudine (AZT) or Tenofovir (TDF) are recommended as less toxic and equally effective alternatives.

建議使用毒性更小但效果相同的齊多夫定(AZT)或泰諾·福韋(TDF)作為替代品。

8.Objective to develop zidovudine tablets and to study its quality-control method.

目的制備齊多夫定片并探討其質(zhì)量控制方法。